FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311459810> ?p ?o ?g. }

• W4311459810 endingPage "47" @default.
• W4311459810 startingPage "42" @default.
• W4311459810 abstract "Current treatments for chronic pancreatitis focus on symptom management and therapeutics targeting disease reversal are lacking. Given the role of the cyclooxygenase-2 (COX-2) enzyme in producing prostaglandin E2 (PGE2), a key component in the inflammatory pathway of chronic pancreatitis, this study evaluates the physiologic effect of oral indomethacin, a COX-2 inhibitor, on PGE2 levels in pancreatic fluid.This pilot two-center randomized controlled trial seeks to examine 32 subjects with chronic pancreatitis who have no contraindications to indomethacin. Subjects will be randomized to either oral indomethacin 50 mg twice a day or placebo twice a day for a total of 28 days. Baseline (pre-treatment) assessment of pain and quality of life will be performed using the Brief Pain Inventory and the PROMIS-10 questionnaires, respectively. Biological specimens including blood, urine, and saliva will be collected at pre-treatment and post-treatment(day 28). Endoscopic pancreatic function testing with concomitant pancreatic fluid collection will also be performed pre- and post-treatment to assess the change in pancreatic fluid PGE2 levels. The relationship between pancreatic fluid PGE2 levels with blood and saliva PGE2 levels will be examined.This study will elucidate the effect of oral indomethacin on PGE2 levels in the pancreas to assess its role in the inflammatory pathway of chronic pancreatitis. Should indomethacin significantly reduce PGE2 levels, this may represent a potential disease-altering treatment for chronic pancreatitis." @default.
• W4311459810 created "2022-12-26" @default.
• W4311459810 creator A5003145416 @default.
• W4311459810 creator A5003348560 @default.
• W4311459810 creator A5004563285 @default.
• W4311459810 creator A5010594561 @default.
• W4311459810 creator A5012767113 @default.
• W4311459810 creator A5032094154 @default.
• W4311459810 creator A5036774311 @default.
• W4311459810 creator A5038172784 @default.
• W4311459810 creator A5040313520 @default.
• W4311459810 creator A5042385064 @default.
• W4311459810 creator A5046429346 @default.
• W4311459810 creator A5056227666 @default.
• W4311459810 creator A5079103072 @default.
• W4311459810 creator A5086645253 @default.
• W4311459810 date "2023-01-01" @default.
• W4311459810 modified "2023-10-14" @default.
• W4311459810 title "The phase 1/2 trial of indomethacin in chronic pancreatitis (The PAIR trial): Protocol for a parallel multi-center randomized controlled trial" @default.
• W4311459810 cites W1979274524 @default.
• W4311459810 cites W1989338627 @default.
• W4311459810 cites W1998531750 @default.
• W4311459810 cites W2008821783 @default.
• W4311459810 cites W2035210768 @default.
• W4311459810 cites W2053302654 @default.
• W4311459810 cites W2055853242 @default.
• W4311459810 cites W2078272869 @default.
• W4311459810 cites W2080082190 @default.
• W4311459810 cites W2100650200 @default.
• W4311459810 cites W2107748660 @default.
• W4311459810 cites W2112743312 @default.
• W4311459810 cites W2135294439 @default.
• W4311459810 cites W2144282451 @default.
• W4311459810 cites W2166219932 @default.
• W4311459810 cites W2282364445 @default.
• W4311459810 cites W2320909684 @default.
• W4311459810 cites W2325719364 @default.
• W4311459810 cites W2526450495 @default.
• W4311459810 cites W2896422686 @default.
• W4311459810 cites W2897031692 @default.
• W4311459810 cites W2897549962 @default.
• W4311459810 cites W2419132834 @default.
• W4311459810 doi "https://doi.org/10.1016/j.pan.2022.12.008" @default.
• W4311459810 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36535851" @default.
• W4311459810 hasPublicationYear "2023" @default.
• W4311459810 type Work @default.
• W4311459810 citedByCount "1" @default.
• W4311459810 countsByYear W43114598102023 @default.
• W4311459810 crossrefType "journal-article" @default.
• W4311459810 hasAuthorship W4311459810A5003145416 @default.
• W4311459810 hasAuthorship W4311459810A5003348560 @default.
• W4311459810 hasAuthorship W4311459810A5004563285 @default.
• W4311459810 hasAuthorship W4311459810A5010594561 @default.
• W4311459810 hasAuthorship W4311459810A5012767113 @default.
• W4311459810 hasAuthorship W4311459810A5032094154 @default.
• W4311459810 hasAuthorship W4311459810A5036774311 @default.
• W4311459810 hasAuthorship W4311459810A5038172784 @default.
• W4311459810 hasAuthorship W4311459810A5040313520 @default.
• W4311459810 hasAuthorship W4311459810A5042385064 @default.
• W4311459810 hasAuthorship W4311459810A5046429346 @default.
• W4311459810 hasAuthorship W4311459810A5056227666 @default.
• W4311459810 hasAuthorship W4311459810A5079103072 @default.
• W4311459810 hasAuthorship W4311459810A5086645253 @default.
• W4311459810 hasConcept C126322002 @default.
• W4311459810 hasConcept C142724271 @default.
• W4311459810 hasConcept C168563851 @default.
• W4311459810 hasConcept C204787440 @default.
• W4311459810 hasConcept C27081682 @default.
• W4311459810 hasConcept C2775967933 @default.
• W4311459810 hasConcept C2777956040 @default.
• W4311459810 hasConcept C2779384505 @default.
• W4311459810 hasConcept C504460877 @default.
• W4311459810 hasConcept C71924100 @default.
• W4311459810 hasConcept C90924648 @default.
• W4311459810 hasConceptScore W4311459810C126322002 @default.
• W4311459810 hasConceptScore W4311459810C142724271 @default.
• W4311459810 hasConceptScore W4311459810C168563851 @default.
• W4311459810 hasConceptScore W4311459810C204787440 @default.
• W4311459810 hasConceptScore W4311459810C27081682 @default.
• W4311459810 hasConceptScore W4311459810C2775967933 @default.
• W4311459810 hasConceptScore W4311459810C2777956040 @default.
• W4311459810 hasConceptScore W4311459810C2779384505 @default.
• W4311459810 hasConceptScore W4311459810C504460877 @default.
• W4311459810 hasConceptScore W4311459810C71924100 @default.
• W4311459810 hasConceptScore W4311459810C90924648 @default.
• W4311459810 hasFunder F4320332161 @default.
• W4311459810 hasIssue "1" @default.
• W4311459810 hasLocation W43114598101 @default.
• W4311459810 hasLocation W43114598102 @default.
• W4311459810 hasOpenAccess W4311459810 @default.
• W4311459810 hasPrimaryLocation W43114598101 @default.
• W4311459810 hasRelatedWork W1859326399 @default.
• W4311459810 hasRelatedWork W2067177021 @default.
• W4311459810 hasRelatedWork W2103600127 @default.
• W4311459810 hasRelatedWork W2128056956 @default.
• W4311459810 hasRelatedWork W2539791946 @default.
• W4311459810 hasRelatedWork W3045507769 @default.
• W4311459810 hasRelatedWork W3129847635 @default.

• next